<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="article-commentary"><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">0376333</journal-id><journal-id journal-id-type="pubmed-jr-id">5218</journal-id><journal-id journal-id-type="nlm-ta">J Psychosom Res</journal-id><journal-id journal-id-type="iso-abbrev">J Psychosom Res</journal-id><journal-title-group><journal-title>Journal of psychosomatic research</journal-title></journal-title-group><issn pub-type="ppub">0022-3999</issn><issn pub-type="epub">1879-1360</issn></journal-meta><article-meta><article-id pub-id-type="pmid">31376881</article-id><article-id pub-id-type="pmc">7561027</article-id><article-id pub-id-type="doi">10.1016/j.jpsychores.2019.109732</article-id><article-id pub-id-type="manuscript">NIHMS1634246</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Personality and the opioid epidemic</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Turiano</surname><given-names>Nicholas A.</given-names></name><xref rid="CR1" ref-type="corresp">*</xref></contrib><aff id="A1">West Virginia University Department of Psychology, West Virginia Prevention Research Center, Morgantown, WV, United
States of America</aff></contrib-group><author-notes><corresp id="CR1"><label>*</label>Corresponding author. <email>nicholas.turiano@mail.wvu.edu</email>.</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>8</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>29</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="ppub"><month>8</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>10</month><year>2020</year></pub-date><volume>123</volume><fpage>109732</fpage><lpage>109732</lpage><!--elocation-id from pubmed: 10.1016/j.jpsychores.2019.109732--><related-article related-article-type="commentary-article" xlink:href="6679987" ext-link-type="pmcid" id="ra1"/></article-meta></front><body><p id="P1">Sutin and colleagues' article, &#x0201c;The Prospective Association between Personality Traits and Persistent Pain and Opioid
Medication Use&#x0201d;, examines key psychological constructs that may help explain who is at risk for opioid abuse [<xref rid="R1" ref-type="bibr">1</xref>]. The timeliness of the article is exceptional as researchers, physicians, drug-makers, and countless
families debate on how to remedy the nation's ever increasing opioid epidemic [<xref rid="R2" ref-type="bibr">2</xref>]. Stemming
partly from a medical system push in the early-2000s to better treat pain, opioids were the go-to pain reliever. Many of these
prescriptions were for legitimate pain issues and prescribers were often unaware of the potential dangers of opioids, but widespread
opioid abuse and dependence quickly spread across the nation. It was estimated that over 245 million prescriptions for opioid-related
medications were dispensed in 2014 with over 10 million individuals misusing their opioid prescriptions. Fast forward to 2017, and we now
have over 47,000 Americans dying from an opioid-related overdose [<xref rid="R3" ref-type="bibr">3</xref>] and an estimated 1.7 million
suffering from an opioid-prescription substance use disorder [<xref rid="R4" ref-type="bibr">4</xref>]. With incidence rates continuing to
rise in the United States and internationally [<xref rid="R5" ref-type="bibr">5</xref>], a public health emergency was declared for what
is now coined the <italic>Opioid Epidemic</italic>.</p><p id="P2">Treating chronic pain is important for improving quality of life, which is especially true in an increasingly aging population.
Persistent pain is one of the most commonly reported problems older adults seek medical care for because it can have detrimental effects
on mobility, sleep, and mood [<xref rid="R6" ref-type="bibr">6</xref>]. However, in the midst of the Opioid Epidemic, there is little
agreement on how to best treat chronic pain without increasing the risk of developing a substance use disorder [<xref rid="R7" ref-type="bibr">7</xref>]. Some suggest the development of more effective substance abuse treatment programs, refinement of
abuse-deterrent formulations, or more effective medication-assisted therapies [<xref rid="R2" ref-type="bibr">2</xref>]. Opponents point
out that these changes do not prevent opioid addiction, they just treat the symptoms after the addiction has already occurred. Others
believe the key remedy is additional training in how to effectively prescribe and use opioids. Tightening regulation around how opioids
are prescribed and harsher penalties for those that disregard these guidelines is also suggested. However, the fact remains that even when
prescribed properly, a significant portion of the population will abuse or become addicted to opioids. What is needed are better models to
predict who is at the greatest risk for opioid misuse. Since individual differences in personality traits have emerged as robust
predictors of health and behavior over the entire lifespan [<xref rid="R8" ref-type="bibr">8</xref>], personality assessment might be one
effective way to predict abuse of opioid medications and subsequently inform evidence-based prevention and intervention strategies.</p><p id="P3">Ample studies implicate low conscientiousness (e.g., high levels of responsibility and discipline) and high neuroticism (e.g., high
depressed affect, emotional reactivity) as robust predictors of alcohol and tobacco use across the entire lifespan [<xref rid="R9" ref-type="bibr">9</xref>]. Fewer have explored associations between personality traits and specific misuse of prescription pain
medicine, but the general pattern of findings suggests that those who are low in conscientiousness are more likely to use marijuana,
cocaine, and heroin, while those higher in neuroticism are more likely to use cocaine and heroin [<xref rid="R10" ref-type="bibr">10</xref>]. Moreover, a few studies even show these traits are associated with opioid dependence [<xref rid="R11" ref-type="bibr">11</xref>] or mixed drug-related substance use disorder [<xref rid="R12" ref-type="bibr">12</xref>].</p><p id="P4">Personality assessment can be used in at least three distinct ways to combat opioid abuse: 1.) identifying those at risk; 2.)
tailoring existing interventions; and 3.) targeting personality for change via interventions.</p><p id="P5">First, personality assessment is a quick and effective method of identifying those at risk for experiencing pain and seeking
prescriptions to alleviate pain [<xref rid="R1" ref-type="bibr">1</xref>]. For example, a short personality assessment incorporated into a
medical chart could be viewed by a prescribing doctor prior to dispensing any opioid medication. Those scoring higher in neuroticism and
lower in conscientiousness are more likely to present to doctors with pain [<xref rid="R1" ref-type="bibr">1</xref>] so it may not be that
these individuals are just engaging in drug seeking behavior. By knowing there is an increased risk of abuse by these individuals, it is
possible to explore other alternatives to opioids, such as other analgesic medications with a lower abuse liability or non-pharmacological
interventions such as physical therapy. To prevent stockpiles of un-used opioids, prescribers can also stop assuaging patient's
fears about future pain and refrain from providing 30 days worth of pills for something that can be treated in just a few days [<xref rid="R13" ref-type="bibr">13</xref>].</p><p id="P6">The National Institutes of Health Precision Medicine Initiative involves multiple national research/medical centers that aim to
understand how a person's genetics, environment, and lifestyle can help determine the best approach to prevent or treat disease.
Personality assessment is one means to use Precision Medicine in the fight against the Opioid Epidemic by tailoring existing treatments
based on personality profiles [<xref rid="R14" ref-type="bibr">14</xref>]. For example, by better knowing a person's relatively
enduring thoughts, behaviors, and emotions (their personality), treatment providers will better understand many factors surrounding their
patients' drug use such as their strengths and weaknesses, possible triggers, their propensity to experience stress, and their
typical use of coping mechanisms. All of this information can assist in developing a strong therapeutic alliance which is necessary for
better treatment outcomes.</p><p id="P7">Personality assessment can also be used to monitor certain individuals after they are prescribed the medications. Since those
scoring higher in neuroticism and lower in conscientiousness are more likely to use the opioids in ways not directed by their doctor
[<xref rid="R1" ref-type="bibr">1</xref>], it would be beneficial to give very clear directions on how the medication should be taken
and the possible risk factors of taking it differently (e.g., crushing pills, taking with alcohol, etc.). Most people do not read the
information inserts associated with prescriptions and this might be especially true for those scoring low in conscientiousness and high in
neuroticism. Other strategies could include phone-based check-ins to determine how the medication is working, ensuring the daily maximum
dose is not being exceeded, what to do with left-over pills, and ensuring the risks of longer-term use are discussed before a refill is
given. These strategies are already in use to a certain degree, but integrating personality assessment into assessment of risk will allow
for more tailored use. With healthcare personnel time already limited, focusing scarce resources on individuals most at-risk for
prescription opioid abuse will be both time and cost effective.</p><p id="P8">Integrating personality assessment along with other standard assessments at treatment initiation can also aid in determining
treatment engagement. Personality scores can identify who is less likely to engage/participate in treatment and who is more likely to
drop-out of treatment and/or relapse [<xref rid="R14" ref-type="bibr">14</xref>]. For example, individuals in Poland with substance use
disorder who remained abstinent eight weeks after treatment scored higher in agreeableness and conscientiousness, and lower in neuroticism
[<xref rid="R15" ref-type="bibr">15</xref>]. They also had greater participation and adaptability throughout the treatment. Knowing
those most likely to withdraw from treatment at the outset can help providers direct the necessary resources to keep those individuals
engaged in care and reduce obstacles to treatment. There is also preliminary work being done with alcohol abuse treatment programs trying
to match clients to particular therapies based on personality [<xref rid="R16" ref-type="bibr">16</xref>]. Such matching procedures could
be done with specific opioid treatments [<xref rid="R14" ref-type="bibr">14</xref>] and individuals could be counseled on how their
personality characteristics might influence their emotions and behaviors over the course of treatment.</p><p id="P9">A final use of personality assessment in combatting the Opioid Epidemic is the movement to therapeutically modify personality
traits. Personality psychologists have compiled compelling evidence that personality traits can be modified through existing
interventions/therapies for mental health or substance use disorders (e.g., cognitive behavioral therapy, spiritual therapy).
Specifically, personality trait levels changed in more adaptive directions through treatment and those experiencing more optimal treatment
outcomes are the ones that showed this persistent personality change [<xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R18" ref-type="bibr">18</xref>]. The rationale of targeting personality with interventions is that if you modify personality as an
underlying root cause for behavioral problems (e.g., the lack of self-control, negative emotionality, depressed affect, lack of
responsibility and planning) there will be widespread improvements in behavior, well-being, and health [<xref rid="R19" ref-type="bibr">19</xref>]. One application of this would be at-risk youth being targeted for personality intervention to give them the behavioral,
cognitive, and emotional skills needed to avoid opioid use. Overall, combining standard opioid dependence treatments along with targeted
personality interventions may be the most effective means of combating the Opioid Epidemic.</p><p id="P10">Opioid abuse is an escalating international problem. The many complexities underlying this epidemic make it extremely difficult to
combat. Personality assessment is not the ultimate key to reducing opioid abuse, but it can be one important component of future efforts
to preventing and treating opioid addiction. Future work should focus on collecting data from larger and more representative samples and
gathering more detailed information on the progression of opioid abuse. For example, understanding exactly how use initiated and escalated
will provide better understanding of risk-factors and possible points of intervention. More research is also needed on traits such as
extraversion and openness because current findings are mixed. Lastly, identifying how personality levels change during the course of
opioid addiction and treatment will be key for future interventions.</p></body><back><ack id="S1"><title>Acknowledgement</title><p id="P11">This publication is a product of the West Virginia Prevention Research Center and was supported by Cooperative Agreement
Number 1-U48-DP-005004 from the Centers for Disease Control and Prevention. The findings and conclusions in this are those of the
author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention.</p></ack><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><name><surname>Sutin</surname><given-names>A</given-names></name>, <name><surname>Stephan</surname><given-names>Y</given-names></name>, <name><surname>Luchetti</surname><given-names>M</given-names></name>, <name><surname>Terracciano</surname><given-names>A</given-names></name>, <article-title>The prospective association between personality traits and persistent pain and opioid medication
use</article-title>, <source>J Psychosom Res</source>. (<year>2019</year>) <fpage>109721</fpage>.<pub-id pub-id-type="pmid">31103210</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><name><surname>Skolnick</surname><given-names>P</given-names></name>, <article-title>The opioid epidemic: crisis and solutions</article-title>, <source>Annu. Rev. Pharmacol. Toxicol</source>
<volume>58</volume> (<year>2018</year>) <fpage>143</fpage>&#x02013;<lpage>159</lpage>.<pub-id pub-id-type="pmid">28968188</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><name><surname>Kochanek</surname><given-names>KD</given-names></name>, <name><surname>Murphy</surname><given-names>SL</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name>, <name><surname>Arias</surname><given-names>E</given-names></name>, <article-title>Mortality in the United States 2016</article-title>, <source>NCHS Data Brief</source>
(<year>2016</year>).</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="book"><collab>Substance Abuse and Mental Health Services Administration</collab>, <source>Key
substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health
(HHS Publication No. SMA 17-5044, NSDUH Series H-52)</source>. <publisher-loc>Rockville, MD</publisher-loc>:
<publisher-name>Center for Behavioral Health Statistics and Quality, Subst. Abus</publisher-name>
(<year>2017</year>).</mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><name><surname>Morley</surname><given-names>KI</given-names></name>, <name><surname>Ferris</surname><given-names>JA</given-names></name>, <name><surname>Winstock</surname><given-names>AR</given-names></name>, <name><surname>Lynskey</surname><given-names>MT</given-names></name>, <article-title>Polysubstance use and misuse or abuse of prescription opioid analgesics: a multi-level analysis of
international data</article-title>, <source>Pain</source>
<volume>158</volume> (<year>2017</year>) <fpage>1138</fpage>&#x02013;<lpage>1144</lpage>.<pub-id pub-id-type="pmid">28267061</pub-id></mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><name><surname>Molton</surname><given-names>IR</given-names></name>, <name><surname>Terrill</surname><given-names>AL</given-names></name>, <article-title>Overview of persistent pain in older adults</article-title>, <source>Am Psychol</source>
<volume>69</volume> (<year>2014</year>) <fpage>197</fpage>&#x02013;<lpage>207</lpage>.<pub-id pub-id-type="pmid">24547805</pub-id></mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><name><surname>Volkow</surname><given-names>ND</given-names></name>, <name><surname>McLellan</surname><given-names>AT</given-names></name>, <article-title>Opioid abuse in chronic pain&#x02014;misconceptions and mitigation strategies</article-title>, <source>N.
Engl. J. Med</source>
<volume>374</volume> (<year>2016</year>) <fpage>1253</fpage>&#x02013;<lpage>1263</lpage>.<pub-id pub-id-type="pmid">27028915</pub-id></mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="book"><name><surname>Hampson</surname><given-names>SE</given-names></name>, <name><surname>Friedman</surname><given-names>HS</given-names></name>, <chapter-title>Personality and health: a lifespan perspective</chapter-title>, in: <name><surname>John</surname><given-names>OP</given-names></name>, <name><surname>Robins</surname><given-names>RW</given-names></name>, <name><surname>Pervin</surname><given-names>LA</given-names></name> (Eds.), <source>Handbook of Personality: Theory and Research</source>, <publisher-name>The Guilford
Press</publisher-name>, <publisher-loc>New York, NY, US</publisher-loc>, <year>2008</year>, pp.
<fpage>770</fpage>&#x02013;<lpage>794</lpage>.</mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><name><surname>Bogg</surname><given-names>T</given-names></name>, <name><surname>Roberts</surname><given-names>BW</given-names></name>, <article-title>Conscientiousness and health-related behaviors: a meta-analysis of the leading behavioral contributors to
mortality</article-title>, <source>Psychol. Bull</source>
<volume>130</volume> (<year>2004</year>) <fpage>887</fpage>&#x02013;<lpage>919</lpage>.<pub-id pub-id-type="pmid">15535742</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><name><surname>Terracciano</surname><given-names>A</given-names></name>, <name><surname>L&#x000f6;ckenhoff</surname><given-names>C</given-names></name>, <name><surname>Crum</surname><given-names>RM</given-names></name>, <name><surname>Bienvenu</surname><given-names>OJ</given-names></name>, <name><surname>Costa</surname><given-names>PT</given-names></name>, <article-title>Five-Factor Model personality profiles of drug users</article-title>, <source>BMC Psychiatry</source>
<volume>8</volume> (<year>2008</year>) <fpage>22</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">18405382</pub-id></mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><name><surname>Korn&#x000f8;r</surname><given-names>H</given-names></name>, <name><surname>Nordvik</surname><given-names>H</given-names></name>, <article-title>Five-factor model personality traits in opioid dependence</article-title>, <source>BMC Psychiatry</source>
<volume>7</volume> (<year>2007</year>) <fpage>37</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">17683593</pub-id></mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><name><surname>Kotov</surname><given-names>R</given-names></name>, <name><surname>Gamez</surname><given-names>W</given-names></name>, <name><surname>Schmidt</surname><given-names>F</given-names></name>, <name><surname>Watson</surname><given-names>D</given-names></name>, <article-title>Linking &#x0201c;big&#x0201d; personality traits to anxiety, depressive, and substance use disorders: a
meta-analysis</article-title>, <source>Psychol. Bull</source>
<volume>136</volume> (<year>2010</year>) <fpage>768</fpage>&#x02013;<lpage>821</lpage>.<pub-id pub-id-type="pmid">20804236</pub-id></mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><name><surname>Henry</surname><given-names>SG</given-names></name>, <name><surname>Paterniti</surname><given-names>DA</given-names></name>, <name><surname>Feng</surname><given-names>B</given-names></name>, <name><surname>Iosif</surname><given-names>AM</given-names></name>, <name><surname>Kravitz</surname><given-names>RL</given-names></name>, <name><surname>Weinberg</surname><given-names>G</given-names></name>, <name><surname>Cowan</surname><given-names>P</given-names></name>, <name><surname>Verba</surname><given-names>S</given-names></name>, <article-title>Patients' experience with opioid tapering: a conceptual model with recommendations for
clinicians</article-title>, <source>J. Pain</source>
<volume>20</volume> (<year>2019</year>) <fpage>181</fpage>&#x02013;<lpage>191</lpage>.<pub-id pub-id-type="pmid">30243859</pub-id></mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><name><surname>Staiger</surname><given-names>PK</given-names></name>, <name><surname>Kambouropoulos</surname><given-names>N</given-names></name>, <name><surname>Dawe</surname><given-names>S</given-names></name>, <article-title>Should personality traits be considered when refining substance misuse treatment programs?</article-title>
<source>Drug Alcohol Rev</source>
<volume>26</volume> (<year>2007</year>) <fpage>17</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">17364832</pub-id></mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><name><surname>Betkowska-Korpa&#x00142;a</surname><given-names>B</given-names></name>, <article-title>Personality in the big five model and maintaining abstinence after one year follow-up</article-title>,
<source>Psychiatr. Pol</source>
<volume>46</volume> (<year>2012</year>) <fpage>387</fpage>&#x02013;<lpage>399</lpage>.<pub-id pub-id-type="pmid">23045892</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><name><surname>Conrod</surname><given-names>PJ</given-names></name>, <name><surname>Stewart</surname><given-names>SH</given-names></name>, <name><surname>Pihl</surname><given-names>RO</given-names></name>, <name><surname>Cote</surname><given-names>S</given-names></name>, <name><surname>Fontaine</surname><given-names>V</given-names></name>, <name><surname>Dongier</surname><given-names>M</given-names></name>, <article-title>Efficacy of brief coping skills interventions that match different personality profiles of female
substance abusers</article-title>, <source>Psychol. Addict. Behav</source>
<volume>14</volume> (<year>2000</year>) <fpage>231</fpage>&#x02013;<lpage>242</lpage>.<pub-id pub-id-type="pmid">10998949</pub-id></mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><name><surname>Piedmont</surname><given-names>RL</given-names></name>, <article-title>Cracking the plaster cast: big five personality change during intensive outpatient
counseling</article-title>, <source>J. Res. Pers</source>
<volume>35</volume> (<year>2001</year>) <fpage>500</fpage>&#x02013;<lpage>520</lpage>.</mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><name><surname>Roberts</surname><given-names>BW</given-names></name>, <name><surname>Luo</surname><given-names>J</given-names></name>, <name><surname>Briley</surname><given-names>DA</given-names></name>, <name><surname>Chow</surname><given-names>PI</given-names></name>, <name><surname>Su</surname><given-names>R</given-names></name>, <name><surname>Hill</surname><given-names>PL</given-names></name>, <article-title>A systematic review of personality trait change through intervention</article-title>, <source>Psychol.
Bull</source>
<volume>143</volume> (<year>2017</year>) <fpage>117</fpage>&#x02013;<lpage>142</lpage>.<pub-id pub-id-type="pmid">28054797</pub-id></mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><name><surname>Moffitt</surname><given-names>TE</given-names></name>, <name><surname>Arseneault</surname><given-names>L</given-names></name>, <name><surname>Belsky</surname><given-names>D</given-names></name>, <name><surname>Dickson</surname><given-names>N</given-names></name>, <name><surname>Hancox</surname><given-names>RJ</given-names></name>, <name><surname>Harrington</surname><given-names>H</given-names></name>, <name><surname>Houts</surname><given-names>R</given-names></name>, <name><surname>Poulton</surname><given-names>R</given-names></name>, <name><surname>Roberts</surname><given-names>BW</given-names></name>, <name><surname>Ross</surname><given-names>S</given-names></name>, <name><surname>Sears</surname><given-names>MR</given-names></name>, <name><surname>Thomson</surname><given-names>WM</given-names></name>, <name><surname>Caspi</surname><given-names>A</given-names></name>, <article-title>A gradient of childhood self-control predicts health, wealth, and public safety</article-title>,
<source>Proc. Natl. Acad. Sci</source>
<volume>108</volume> (<year>2011</year>) <fpage>2693</fpage>&#x02013;<lpage>2698</lpage>.<pub-id pub-id-type="pmid">21262822</pub-id></mixed-citation></ref></ref-list></back></article>